Abstract
Background: Cervical involvement in endometrial carcinoma is a diverse entity, and the optimal management of these patients is not well understood.
Methods: Recurrence patterns and complications in 202 patients with histologically confirmed endometrial carcinoma with cervical involvement were retrospectively studied.
Results: The 5-year actuarial survival rate for all patients was 65%. Recurrences were documented in 80 (40%) of the patients, and the overall long-term survival rate in this group was 4%. Patients treated with radical hysterectomy (n=33) had a 6% isolated pelvic recurrence rate and the lowest serious complication rate among the five treatment groups despite having the highest frequency of risk factors for recurrence among any of the groups studied. Patients treated with extrafascial hysterectomy alone (n=37) had a 14% pelvic recurrence rate and very few complications. When radiotherapy preceded extrafascial hysterectomy (n=37), the frequency of pelvic recurrences was 30%, and 19% experienced serious gastrointestinal or genitourinary tract complications. When radiotherapy followed extrafascial hysterectomy (n=68), the pelvic recurrence rate was 24%, and 13% experienced serious complications. Overall, 24% of patients (49 of 202) had isolated pelvic recurrences, whereas 10% (21 of 202) had isolated distant recurrences and 5% (10 of 202) were simulataneously diagnosed with both pelvic and distant recurrences.
Conclusions: This large data base suggests that older conventional forms of therapy, particularly those using preoperative radiotherapy, subject the patient to significant morbidity over a 5- to 10-year period and, in terms of local control, are not necessarily superior to therapeutic modalities using primary surgical evaluation, such as radical hysterectomy. Consideration of primary surgery should be given in the appropriate situation, and radical hysterectomy should be considered when gross cervical involvement is encountered and intraoperative exploration does not show obvious extrauterine disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
FIGO news: Corpus cancer staging.Int J Gynaecol Obstet 1989;28:190.
Mannel RS, Berman ML, Walker JL, Manetta A, DiSaia PJ. Management of endometrial cancer with suspected cervical involvement.Obstet Gynecol 1990;75:116–21.
Boente MP, Yordan EL, McIntosh DG, et al. Prognostic factors and long-term survival in stage II endometrial carcinoma.Gynecol Oncol 1993;51:316–22.
Onsrud M, Aalders J, Abeler V, Taylor P. Endometrial carcinoma with cervical involvement (stage II): prognostic factors and value of combined radiological-surgical treatment.Gynecol Oncol 1982;13:76–86.
Berman ML, Afridi MA, Kanbour AI, Ball HG. Risk factors and prognosis in stage II endometrial cancer.Gynecol Oncol 1982;14:49–61.
Boronow RC, ed.Carcinoma of the corpus. Treatment at M.D. Anderson Hospital (cancer of the uterus and ovary). Chicago, IL: Year Book Medical, 1969.
DiSaia PJ, Creasman WT. Adenocarcinoma of the uterine corpus (clinical gynecologic oncology). St. Louis, MO: CV Mosby, 1993.
Wallin TE, Malkasian GD Jr, Gaffey TA, O'Brien PC, Fountain KS. Stage II cancer of the endometrium: a pathologic and clinical study.Gynecol Oncol 1984;18:1–17.
Homesley HD, Boronow RC, Lewis JL Jr. Stage II endometrial adenocarcinoma.Obstet Gynecol 1977;49:604–8.
Nie NH, Hull CH, Jenkins G, Steinbrenner DH.SPSS: statistical package for the social sciences. 2nd ed. New York: McGraw-Hill, 1975.
Kottmeier HL, ed.Annual report on the results of treatment in gynecologic cancer. Stockholm, Sweden: International Federation of Gynecology and Obstetrics, 1982.
Soisson AP, Soper JT, Berchuck A, Dodge R, Clarke-Pearson D. Radical hysterectomy in obese women.Obstet Gynecol 1992;80:940–3.
Nahhas WA, Zaino R, Mortel R. Residual carcinoma of the surgical specimen of patients with adenocarcinoma undergoing preoperative radiation therapy.Gynecol Oncol 1984;18:165–76.
Larson DM, Copeland LJ, Gallager HS, Kong JP, Wharton JT, Stringer CA. Stage II endometrial carcinoma: results and complications of a combined radiotherapeutic-surgical approach.Cancer 1988;61:1528–34.
Trimble EL, Jones HW III. Management of stage II endometrial cancer.Obstet Gynecol 1988;71:323–6.
Rubin SC, Hoskins WJ, Saigo PE, Nori D, Mychalczak B, Chapman D, et al. Management of endometrial adenocarcinoma with cervical involvement.Gynecol Oncol 1993;45:294–8.
Surwit EA, Fowler WC Jr, Rogoff EE. Stage II carcinoma of the endometrium: an analysis of treatment.Obstet Gynecol 1978;52:97–9.
Lanciano RM, Curran WJ, Grevan KM, et al. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium.Gynecol Oncol 1990;39:368–73.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boente, M.P., Orandi, Y.A., Yordan, E.L. et al. Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement. Annals of Surgical Oncology 2, 138–144 (1995). https://doi.org/10.1007/BF02303629
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02303629